HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 129 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $271,000 | -30.0% | 30,584 | 0.0% | 0.00% | -50.0% |
Q2 2022 | $387,000 | -33.2% | 30,584 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $579,000 | -27.4% | 30,584 | +36.8% | 0.00% | -33.3% |
Q4 2021 | $797,000 | -2.7% | 22,361 | 0.0% | 0.00% | -25.0% |
Q3 2021 | $819,000 | +29.0% | 22,361 | +38.2% | 0.00% | +33.3% |
Q2 2021 | $635,000 | +38.9% | 16,179 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $457,000 | -11.8% | 16,179 | 0.0% | 0.00% | -25.0% |
Q4 2020 | $518,000 | +28.9% | 16,179 | +30.1% | 0.00% | 0.0% |
Q3 2020 | $402,000 | -5.9% | 12,434 | -19.7% | 0.00% | -20.0% |
Q2 2020 | $427,000 | +120.1% | 15,480 | +42.4% | 0.01% | +66.7% |
Q1 2020 | $194,000 | -32.6% | 10,867 | 0.0% | 0.00% | -25.0% |
Q4 2019 | $288,000 | +48.5% | 10,867 | 0.0% | 0.00% | +33.3% |
Q3 2019 | $194,000 | +25.2% | 10,867 | +54.4% | 0.00% | 0.0% |
Q2 2019 | $155,000 | -27.9% | 7,038 | 0.0% | 0.00% | -25.0% |
Q1 2019 | $215,000 | +39.6% | 7,038 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $154,000 | – | 7,038 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zeal Asset Management Ltd | 2,339,885 | $93,421,000 | 21.31% |
UG Investment Advisers Ltd. | 33,155 | $1,302,000 | 2.52% |
Pinz Capital Management, LP | 159,400 | $6,260,000 | 1.88% |
Capital International Sarl | 547,743 | $21,510,000 | 1.86% |
Capital International, Inc./CA/ | 4,391,684 | $172,461,000 | 1.54% |
AIA Group Ltd | 437,118 | $17,380,000 | 1.20% |
York Capital Management Global Advisors, LLC | 182,297 | $7,159,000 | 0.80% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 68,000 | $2,671,000 | 0.70% |
E Fund Management (Hong Kong) Co., Ltd. | 18,579 | $730,000 | 0.46% |
M&G INVESTMENT MANAGEMENT LTD | 4,512,562 | $175,990,000 | 0.44% |